Profile picture

Doctor Filip Surmont

Brugge (Belgium)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

HTD1801 as a multisystem cardio‑kidney‑metabolic therapy in type 2 diabetes: phase 3 SYMPHONY Trials demonstrate early CKM risk modification
Presentation
HTD1801 as a multisystem cardio‑kidney‑metabolic therapy in type 2 diabetes: phase 3 SYMPHONY Trials demonstrate early CKM risk modification
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources